Your browser doesn't support javascript.
loading
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.
Folprecht, G; Pericay, C; Saunders, M P; Thomas, A; Lopez Lopez, R; Roh, J K; Chistyakov, V; Höhler, T; Kim, J-S; Hofheinz, R-D; Ackland, S P; Swinson, D; Kopp, M; Udovitsa, D; Hall, M; Iveson, T; Vogel, A; Zalcberg, J R.
Afiliação
  • Folprecht G; Medical Department I, University Cancer Center, University Hospital Carl Gustav Carus, Dresden, Germany gunnar.folprecht@uniklinikum-dresden.de.
  • Pericay C; Hospital de Sabadell, Corporació Sanitaria Parc Taulí-Institut Universitari, Sabadell, Spain.
  • Saunders MP; Department of Radiotherapy and Oncology, The Christie NHS Foundation Trust, Manchester.
  • Thomas A; Department of Cancer Studies, University of Leicester, Leicester, UK.
  • Lopez Lopez R; Department of Medical Oncology, Hospital Clinico Universitario e Instituto de Investigación, Santiago de Compostela, Spain.
  • Roh JK; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Chistyakov V; Pyatigorsk Cancer Dispensary, Stavropol, Russia.
  • Höhler T; Department I of Internal Medicine, Prosper Hospital, Recklinghausen, Germany.
  • Kim JS; Department of Oncology and Hematology, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Hofheinz RD; Department III of Internal Medicine, University Hospital, Mannheim, Germany.
  • Ackland SP; Department of Medical Oncology, Calvary Mater Hospital, Newcastle Hunter Medical Research Institute and University of Newcastle, Callaghan, Australia.
  • Swinson D; Department of Oncology, St James' Hospital, Leeds, UK.
  • Kopp M; Samara Regional Oncology Dispensary, Samara.
  • Udovitsa D; Oncological Dispensary #2, Sochi, Russia.
  • Hall M; Cancer Services Division, Mount Vernon Cancer Centre, Middlesex.
  • Iveson T; Department of Medical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Vogel A; Clinic of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Zalcberg JR; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Ann Oncol ; 27(7): 1273-9, 2016 07.
Article em En | MEDLINE | ID: mdl-27091810
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Proteínas Recombinantes de Fusão / Neoplasias Colorretais / Receptores de Fatores de Crescimento do Endotélio Vascular / Fluoruracila Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Proteínas Recombinantes de Fusão / Neoplasias Colorretais / Receptores de Fatores de Crescimento do Endotélio Vascular / Fluoruracila Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha